agranulocytosis


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to agranulocytosis: neuroleptic malignant syndrome

a·gran·u·lo·cy·to·sis

 (ā-grăn′yə-lō-sī-tō′sĭs)
n.
An acute condition characterized by a marked decrease in circulating granulocytes, especially neutrophils, and often leading to infection. It is usually drug-induced or caused by exposure to radiation or toxic chemicals.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

agranulocytosis

(əˌɡrænjʊləʊsaɪˈtəʊsɪs)
n
(Pathology) a serious and sometimes fatal illness characterized by a marked reduction of leucocytes, usually caused by hypersensitivity to certain drugs
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

a•gran•u•lo•cy•to•sis

(əˌgræn yə loʊ saɪˈtoʊ sɪs)

n.
an acute blood disorder characterized by a loss of circulating granulocytes, leading to fever and ulcerations of the mucous membranes.
[1925–30]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.agranulocytosis - an acute blood disorder (often caused by radiation or drug therapy) characterized by severe reduction in granulocytes
blood disease, blood disorder - a disease or disorder of the blood
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

a·gran·u·lo·cy·to·sis

n. agranulocitosis, condición aguda causada por la disminución excesiva de leucocitos en la sangre.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
A study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
One Baczol formulation also contained metamizole (or dipyrone), a nonsteroidal antiinflammatory drug formerly widely prescribed outside the United States (under trade names including Analgin, Dipirona, Novalgin, and Optalgin) as an analgesic and antipyretic, and banned by the FDA in 1977 because of its association with agranulocytosis (6).
In 1975, clozapine entered Finland and following reports about clozapine-induced agranulocytosis and related mortality and morbidity in Finland and other countries, it was collected from the market [4].
Leukopenia, Neutropenia, and Agranulocytosis: Leukopenia/ neutropenia has been reported during treatment with antipsychotic agents.
They commonly addressed care of patients with medical conditions, such as agranulocytosis, pyelitis and acute nephritis, or patients receiving new treatments such as sulphathiazole for staphylococcal septicaemia.
Optimal therapy is now perhaps dictated by the appearance of toxicity or adverse effects such as agranulocytosis, liver or renal dysfunction.
Less apparent is any type of inflammatory infiltrate in this pattern that usually occurs in a patient with severe bone marrow suppression or agranulocytosis.
A major hematological side effect of mirtazapine is agranulocytosis. Herein we report a patient with depression that developed severe neutropenia-associated thrombocytopenia during treatment with mirtazapine; the patient was safely treated by switching to another drug.
Clozapine was first developed and marketed in the 1960s, but was withdrawn from use in 1975 because of an associated high risk of agranulocytosis. However the drug returned to use in 1989, following trial results that demonstrated its unique effectiveness in treatment-resistant schizophrenia.
(10) Case reports have also associated pSS and agranulocytosis. (11) This could be from either reduced bone marrow neutrophil production, or increased peripheral destruction.
During this period the patient was admitted in hospital with diarrhoea and febrile agranulocytosis. Neutropenic colitis was diagnosed and confirmed by CT scan, the patient being treated with broad spectrum antibiotics leading to a good recovery.
In controlled hypothyroidism patients, the dentist Hypothyorid patient on propylthiouracil treatment must be monitored for possible agranulocytosis, hypo- proteinemia or bleeding, and a complete blood count lest including prothrombin time be performed before doing any invasive procedure.